Amgen’s Blincyto gets speedy US review for paediatric patients
New immunotherapy for ALL
Read More
Author: George Underwood
Government pushes on with junior doctor contract imposition
The government has ruled out further talks with the British Medical Association and says it has “no choice” but to continue with the imposition of a new contract.
Read MoreNew EU lung cancer indication for Boehringer’s Giotrif
The European Commission has widened the license for Boehringer’s non-small cell lung cancer (NSCLC) drug Giotrif, approving it as the first oral treatment option for patients with squamous cell carcinoma of the lung.
Read MoreNew tax inversion curb won’t affect Baxalta deal, says Shire
Shire says that it expects its purchase of Baxalta to go ahead despite new US laws designed to curb ‘tax inversion’ deals.
Read MorePfizer and Allergan confirm merger termination
Pfizer and Allergan have confirmed that they have mutually agreed to terminate their proposed $160 billion combination deal.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
